Transgenic Salmon Identification
In November 2015, the Food and Drug Administration (FDA), approved for commercialization the first transgenic animal, the AquAdvantage salmon, created by AquaBounty technologies. The AquAdvantage salmon is being approved for sale in several countries since 2016. This transgenic animal was designed to achieve market size about twice as fast as the native species, with accelerated growth being concentrated in its first year of life.
This GM Atlantic salmon (Salmo salar) has a “all-fish” DNA construct containing the promoter and terminator regions of the antifreeze protein (AFP) gene from the ocean pout (Zoarces americanus) linked to the growth hormone coding region (cDNA) from the chinook salmon (Oncorhynchus tshawytscha).
The identification of junction regions between genetic elements is the unequivocal way to prove the presence of transgene constructs. Therefore, we detect in your sample the transgenic DNA construct used in the AquAdvantage salmon.
OUR IDENTIFICATION SERVICE
Contact us for information on how to prepare the sample or request our sampling kit. We guarantee results on different sample.
You receive a report indicating the presence of the transgenic DNA construct in your samples.
Castro C, Amorim M, Moreira F, Pereira F
A method to assemble DNA fragments mimicking junctions of transgenic elements: application to the AquAdvantage salmon
Food Control. 2017. 82: 179-183. DOI: https://doi.org/10.1016/j.foodcont.2017.06.037